aKLmRNA (AKL003)

aKLmRNA (AKL003) is an investigational compound currently undergoing clinical trials. It is designed to modulate the expression of specific proteins through mRNA technology, potentially influencing pathways related to longevity and health optimization. Its exact mechanism and impact on longevity are still under investigation, making it an emerging area of interest.